Skip to main content

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us

https://otc.duke.edu/wp-content/uploads/2022/08/abstract-creative-background-with-light-bulb-RWNKHJ4-1.jpg

DIHI Announces 2019 RFA Innovation Awards

The Duke Institute for Health Innovation (DIHI) has announced that it will support high-potential innovation projects in the areas of population health and analytics, novel patient interactions, new and team-based models of care, and optimization…

Read More

https://otc.duke.edu/wp-content/uploads/2022/08/abstract-creative-background-with-light-bulb-RWNKHJ4-1.jpg

DIHI Announces 2019 RFA Innovation Awards

The Duke Institute for Health Innovation (DIHI) has announced that it will support high-potential innovation projects in the areas of population health and analytics, novel patient interactions, new and team-based models of care, and optimization…

Read More

PhaseBio Reports Full Results from Phase 1 Clinical Trial

PhaseBio Pharmaceuticals, Inc. (NASDAQ: PHAS) announced today that results from their Phase 1 clinical trial of PB2452, a novel reversal agent for the antiplatelet drug ticagrelor, demonstrated that PB2452 provided immediate and sustained reversal of ticagrelor antiplatelet…

Read More

PhaseBio Reports Full Results from Phase 1 Clinical Trial

PhaseBio Pharmaceuticals, Inc. (NASDAQ: PHAS) announced today that results from their Phase 1 clinical trial of PB2452, a novel reversal agent for the antiplatelet drug ticagrelor, demonstrated that PB2452 provided immediate and sustained reversal of ticagrelor antiplatelet…

Read More

https://otc.duke.edu/wp-content/uploads/2022/08/dna-strand-assembling-from-different-elements-STB4YJR-1-1.jpg

Precision Biosciences hoping to raise $100 million through an IPO

DURHAM A biotechnology company based in downtown Durham has filed plans to go public — a move that could net the company around $100 million. Precision BioSciences, which has offices at the historic Venable Center…

Read More

https://otc.duke.edu/wp-content/uploads/2022/08/Vamsee_Pamula_web-1.jpg

Duke ECE Welcomes First Entrepreneur-in-Residence

Vamsee Pamula PhD’01 has a new company–and a new gig as Duke ECE’s first Entrepreneur-in-Residence. There’s no shortage of resources for Duke’s entrepreneurial engineers. Within the Pratt School of Engineering, the dedicated Entrepreneurship @ Duke Engineering program offers…

Read More

https://otc.duke.edu/wp-content/uploads/2022/08/echodyne-image-1.png

Black Sage Selects Echodyne for Security Solutions

3D Radar will Support Systems Integrator in Critical Counter-UAS Applications Echodyne, the manufacturer of innovative, high-performance, small electronically scanned array (ESA) radars for government and commercial markets, announced today that its security radar, EchoGuard, has been…

Read More

https://otc.duke.edu/wp-content/uploads/2022/08/Tepsa-buses-SmartBus-project-768x432-2.jpg

Kymeta & Airbus in Peru to demonstrate ‘SmartBus’ satellite links

Kymeta Corp., the Redmond, Wash.-based company backed by Microsoft co-founder Bill Gates and other investors, has demonstrated the performance of its flat-panel satellite antennas in an unlikely setting: on top of buses traveling throughout Peru.…

Read More

https://otc.duke.edu/wp-content/uploads/2022/08/Nasdaq-Tower_092614_B-1.jpg

Off-the-shelf CAR-T and gene-editing player Precision Bio files $100M IPO

Precision BioSciences is looking to raise up to $100 million in an IPO just a few months after raising $110 million in a series B and bagging a hepatitis B alliance with Gilead. The Durham, North…

Read More